近年来，生物制造的热度居高不下，作为新兴的战略性领域，生物制造因其创新性和对传 统生产方式的颠覆性，被视为新的增长点，有助于推动产业结构优化和经济模式的转变。 2025中国合成生物 制造产业发展白皮书 China's synthetic biomanufacturing industry Development White Paper 领取方式： 关注本公众号，扫码添加下方微信获取 白皮书电子版 添加请备注：单位+职位+姓名 封面一览 Synthetic Biology 深波 1 251 息息与人脉精准链接平台 由药融圈&Synbio深波联合发起，药融圈产业研究院精心编纂的 《2025中国合成生物制造产业发 展白皮书》 （以下简称《研究报告》），已于8月1日 在Synbio China 第三届中国合成生物学"科 学家+企业家+投资家"博览会正式发布！ 本白皮书介绍了生物制造的发展现状及趋势，分析了生物制造的产业链和重点应用方向， 并精选 出中国生物制造产业10大链主企业，整理了15家上市公司合成生物学布局方向以及20大热门品种 ，同时探讨了生物制造面临的挑战，最终提出了针对性的政策建议，供业内参考 。 目录 ...

Core Viewpoint - The Chinese synthetic biology manufacturing industry is experiencing rapid growth, with projections indicating a market size approaching 800 billion yuan in 2024 and nearly 1 trillion yuan in 2025, reflecting a growth rate of 26.2% from 2024. The industry is expected to exceed 1 trillion yuan by 2026 and reach 1,703.7 billion yuan by 2027, driven by policy incentives and technological breakthroughs [2]. Industry Overview - The primary focus of the Chinese synthetic biology manufacturing sector is on biopharmaceutical products, which are projected to reach a market size of 334.3 billion yuan in 2024, accounting for 42.9% of the total industry. The demand for biopharmaceuticals is expected to increase due to the ongoing development of new therapies such as cell and gene therapies [3]. Regional Distribution - The synthetic biology manufacturing industry in China exhibits a "three-legged" structure, with significant contributions from East China, North China, and Central South China. By the first half of 2025, these three regions are expected to collectively exceed 700 billion yuan, with East China leading at 311.5 billion yuan, supported by favorable policies and industrial collaboration [4]. Industry Chain Structure - The synthetic biology manufacturing industry chain consists of upstream raw material supply, midstream product processing, and downstream terminal sales applications. Upstream includes various biomass raw materials and biomanufacturing equipment. Midstream encompasses biopharmaceuticals, bio-foods, agricultural bio-products, bio-based materials, and biofuels. Downstream involves terminal sales and applications in healthcare, agriculture, environmental protection, and daily chemicals [7].